SNF 9007 

SNF 9007 is a cholecystokinin analog. SNF 9007 induces analgesia by acting on δ-1, δ-2, and μ opioid receptors in the mouse brain^[1].

1075.17

C₅₅H₆₆N₁₀O₁₃

137415-20-4

Asp-Tyr-{d-Phe}-Gly-Trp-{Me-Nle}-Asp-Phe-NH2

DY-{d-Phe}-GW-{Me-Nle}-DF-NH2

O=C(N)[C@H](CC1=CC=CC=C1)NC([C@H](CC(O)=O)NC([C@H](CCCC)N(C([C@H](CC2=CNC3=C2C=CC=C3)NC(CNC([C@@H](CC4=CC=CC=C4)NC([C@H](CC5=CC=C(O)C=C5)NC([C@H](CC(O)=O)N)=O)=O)=O)=O)=O)C)=O)=O

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Williams C L, et al. SNF9007: a novel analgesic that acts simultaneously at delta 1, delta 2 and mu opioid receptors[J]. Journal of Pharmacology and Experimental Therapeutics, 1994, 269(2): 750-755.  [Content Brief]